Algorae Issues Directors’ Performance Rights as Three Directors’ Interests Change
1AI: $0.009 +12.50% · MC: $18M
Algorae Pharmaceuticals issued 90 million unquoted performance rights as director remuneration after shareholder approval, completing the issue proposed the previous day. Director notices also report changes in interests linked to the rights issue; the supplied notice excerpt identifies David Hainsworth’s indirect acquisition of rights, while the other directors’ details are truncated.

Comments